nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—NT5E—embryo—muscle cancer	0.0299	0.0652	CbGeAlD
Pentoxifylline—NT5E—smooth muscle tissue—muscle cancer	0.0235	0.0513	CbGeAlD
Pentoxifylline—NT5E—renal system—muscle cancer	0.0226	0.0493	CbGeAlD
Pentoxifylline—NT5E—cardiac atrium—muscle cancer	0.0203	0.0442	CbGeAlD
Pentoxifylline—ADORA2B—smooth muscle tissue—muscle cancer	0.0201	0.0439	CbGeAlD
Pentoxifylline—NT5E—tendon—muscle cancer	0.0177	0.0385	CbGeAlD
Pentoxifylline—NT5E—bone marrow—muscle cancer	0.0171	0.0373	CbGeAlD
Pentoxifylline—NT5E—vagina—muscle cancer	0.0164	0.0357	CbGeAlD
Pentoxifylline—PDE5A—smooth muscle tissue—muscle cancer	0.0153	0.0333	CbGeAlD
Pentoxifylline—NT5E—head—muscle cancer	0.0152	0.033	CbGeAlD
Pentoxifylline—PDE5A—renal system—muscle cancer	0.0147	0.032	CbGeAlD
Pentoxifylline—NT5E—testis—muscle cancer	0.0146	0.0319	CbGeAlD
Pentoxifylline—ADORA2B—vagina—muscle cancer	0.014	0.0306	CbGeAlD
Pentoxifylline—ADORA1—renal system—muscle cancer	0.0139	0.0304	CbGeAlD
Pentoxifylline—ADORA2B—head—muscle cancer	0.013	0.0283	CbGeAlD
Pentoxifylline—ADORA2B—testis—muscle cancer	0.0125	0.0273	CbGeAlD
Pentoxifylline—ADORA1—cardiac atrium—muscle cancer	0.0125	0.0272	CbGeAlD
Pentoxifylline—PDE5A—tendon—muscle cancer	0.0115	0.025	CbGeAlD
Pentoxifylline—PDE4A—testis—muscle cancer	0.0112	0.0243	CbGeAlD
Pentoxifylline—ADORA1—tendon—muscle cancer	0.0109	0.0237	CbGeAlD
Pentoxifylline—ADORA2A—head—muscle cancer	0.0108	0.0235	CbGeAlD
Pentoxifylline—PDE5A—vagina—muscle cancer	0.0106	0.0232	CbGeAlD
Pentoxifylline—ADORA2A—testis—muscle cancer	0.0104	0.0227	CbGeAlD
Pentoxifylline—ADORA1—vagina—muscle cancer	0.0101	0.022	CbGeAlD
Pentoxifylline—PDE5A—head—muscle cancer	0.00983	0.0214	CbGeAlD
Pentoxifylline—PDE5A—testis—muscle cancer	0.0095	0.0207	CbGeAlD
Pentoxifylline—ADORA1—head—muscle cancer	0.00932	0.0203	CbGeAlD
Pentoxifylline—PDE4B—cardiac atrium—muscle cancer	0.00923	0.0201	CbGeAlD
Pentoxifylline—ADORA1—testis—muscle cancer	0.009	0.0196	CbGeAlD
Pentoxifylline—PDE4B—tendon—muscle cancer	0.00804	0.0175	CbGeAlD
Pentoxifylline—PDE4B—bone marrow—muscle cancer	0.00779	0.017	CbGeAlD
Pentoxifylline—Aplastic anaemia—Dactinomycin—muscle cancer	0.00771	0.0143	CcSEcCtD
Pentoxifylline—PDE4B—vagina—muscle cancer	0.00746	0.0163	CbGeAlD
Pentoxifylline—PDE4B—head—muscle cancer	0.0069	0.015	CbGeAlD
Pentoxifylline—PDE4B—testis—muscle cancer	0.00666	0.0145	CbGeAlD
Pentoxifylline—CYP1A2—renal system—muscle cancer	0.00633	0.0138	CbGeAlD
Pentoxifylline—Lacrimation—Doxorubicin—muscle cancer	0.00524	0.00969	CcSEcCtD
Pentoxifylline—Pancytopenia—Dactinomycin—muscle cancer	0.00489	0.00904	CcSEcCtD
Pentoxifylline—Swelling—Etoposide—muscle cancer	0.00489	0.00904	CcSEcCtD
Pentoxifylline—Anaphylactoid reaction—Etoposide—muscle cancer	0.00446	0.00824	CcSEcCtD
Pentoxifylline—Pancytopenia—Vincristine—muscle cancer	0.00437	0.00808	CcSEcCtD
Pentoxifylline—Laryngitis—Doxorubicin—muscle cancer	0.00428	0.00791	CcSEcCtD
Pentoxifylline—Hepatitis—Dactinomycin—muscle cancer	0.00412	0.00762	CcSEcCtD
Pentoxifylline—Scotoma—Doxorubicin—muscle cancer	0.00406	0.0075	CcSEcCtD
Pentoxifylline—Sweating—Vincristine—muscle cancer	0.00393	0.00727	CcSEcCtD
Pentoxifylline—Flushing—Dactinomycin—muscle cancer	0.00383	0.00708	CcSEcCtD
Pentoxifylline—Bronchospasm—Etoposide—muscle cancer	0.00367	0.00678	CcSEcCtD
Pentoxifylline—Erythema—Dactinomycin—muscle cancer	0.00359	0.00664	CcSEcCtD
Pentoxifylline—Pancytopenia—Etoposide—muscle cancer	0.00354	0.00655	CcSEcCtD
Pentoxifylline—Lacrimation increased—Doxorubicin—muscle cancer	0.00335	0.00618	CcSEcCtD
Pentoxifylline—Aplastic anaemia—Methotrexate—muscle cancer	0.00334	0.00618	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Dactinomycin—muscle cancer	0.00333	0.00616	CcSEcCtD
Pentoxifylline—Infestation NOS—Etoposide—muscle cancer	0.00332	0.00615	CcSEcCtD
Pentoxifylline—Infestation—Etoposide—muscle cancer	0.00332	0.00615	CcSEcCtD
Pentoxifylline—Anaemia—Dactinomycin—muscle cancer	0.00332	0.00613	CcSEcCtD
Pentoxifylline—Jaundice—Etoposide—muscle cancer	0.00324	0.00599	CcSEcCtD
Pentoxifylline—Malaise—Dactinomycin—muscle cancer	0.00324	0.00598	CcSEcCtD
Pentoxifylline—Leukopenia—Dactinomycin—muscle cancer	0.00321	0.00594	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Etoposide—muscle cancer	0.00314	0.00581	CcSEcCtD
Pentoxifylline—Back pain—Vincristine—muscle cancer	0.0031	0.00574	CcSEcCtD
Pentoxifylline—Myalgia—Dactinomycin—muscle cancer	0.00306	0.00565	CcSEcCtD
Pentoxifylline—Eructation—Doxorubicin—muscle cancer	0.00303	0.0056	CcSEcCtD
Pentoxifylline—Discomfort—Dactinomycin—muscle cancer	0.00302	0.00558	CcSEcCtD
Pentoxifylline—Influenza like illness—Doxorubicin—muscle cancer	0.00299	0.00553	CcSEcCtD
Pentoxifylline—Salivary hypersecretion—Doxorubicin—muscle cancer	0.00299	0.00553	CcSEcCtD
Pentoxifylline—Anaemia—Vincristine—muscle cancer	0.00296	0.00548	CcSEcCtD
Pentoxifylline—Agitation—Vincristine—muscle cancer	0.00295	0.00545	CcSEcCtD
Pentoxifylline—Oedema—Dactinomycin—muscle cancer	0.00293	0.00542	CcSEcCtD
Pentoxifylline—Infection—Dactinomycin—muscle cancer	0.00291	0.00538	CcSEcCtD
Pentoxifylline—Aplastic anaemia—Doxorubicin—muscle cancer	0.00289	0.00535	CcSEcCtD
Pentoxifylline—Leukopenia—Vincristine—muscle cancer	0.00287	0.00531	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Dactinomycin—muscle cancer	0.00287	0.0053	CcSEcCtD
Pentoxifylline—Cramps of lower extremities—Doxorubicin—muscle cancer	0.00283	0.00524	CcSEcCtD
Pentoxifylline—Anorexia—Dactinomycin—muscle cancer	0.00279	0.00516	CcSEcCtD
Pentoxifylline—Convulsion—Vincristine—muscle cancer	0.00278	0.00514	CcSEcCtD
Pentoxifylline—Flushing—Etoposide—muscle cancer	0.00277	0.00512	CcSEcCtD
Pentoxifylline—Hypertension—Vincristine—muscle cancer	0.00277	0.00512	CcSEcCtD
Pentoxifylline—Myalgia—Vincristine—muscle cancer	0.00273	0.00505	CcSEcCtD
Pentoxifylline—Immune system disorder—Etoposide—muscle cancer	0.0027	0.00498	CcSEcCtD
Pentoxifylline—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00267	0.00494	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00267	0.00493	CcSEcCtD
Pentoxifylline—Oedema—Vincristine—muscle cancer	0.00262	0.00484	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Vincristine—muscle cancer	0.00262	0.00484	CcSEcCtD
Pentoxifylline—Infection—Vincristine—muscle cancer	0.0026	0.00481	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Vincristine—muscle cancer	0.00256	0.00474	CcSEcCtD
Pentoxifylline—Decreased appetite—Dactinomycin—muscle cancer	0.00255	0.00471	CcSEcCtD
Pentoxifylline—Dysgeusia—Etoposide—muscle cancer	0.00254	0.0047	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Vincristine—muscle cancer	0.00253	0.00468	CcSEcCtD
Pentoxifylline—Back pain—Etoposide—muscle cancer	0.00251	0.00465	CcSEcCtD
Pentoxifylline—Vascular purpura—Doxorubicin—muscle cancer	0.0025	0.00462	CcSEcCtD
Pentoxifylline—Muscle spasms—Etoposide—muscle cancer	0.0025	0.00462	CcSEcCtD
Pentoxifylline—Anorexia—Vincristine—muscle cancer	0.0025	0.00461	CcSEcCtD
Pentoxifylline—Hypotension—Vincristine—muscle cancer	0.00245	0.00452	CcSEcCtD
Pentoxifylline—Feeling abnormal—Dactinomycin—muscle cancer	0.00241	0.00446	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Etoposide—muscle cancer	0.00241	0.00446	CcSEcCtD
Pentoxifylline—Anaemia—Etoposide—muscle cancer	0.0024	0.00444	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Dactinomycin—muscle cancer	0.0024	0.00443	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00239	0.00441	CcSEcCtD
Pentoxifylline—Insomnia—Vincristine—muscle cancer	0.00237	0.00438	CcSEcCtD
Pentoxifylline—Malaise—Etoposide—muscle cancer	0.00234	0.00433	CcSEcCtD
Pentoxifylline—Leukopenia—Etoposide—muscle cancer	0.00233	0.0043	CcSEcCtD
Pentoxifylline—Purpura—Doxorubicin—muscle cancer	0.00232	0.00429	CcSEcCtD
Pentoxifylline—Abdominal pain—Dactinomycin—muscle cancer	0.00232	0.00428	CcSEcCtD
Pentoxifylline—Body temperature increased—Dactinomycin—muscle cancer	0.00232	0.00428	CcSEcCtD
Pentoxifylline—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00231	0.00427	CcSEcCtD
Pentoxifylline—Decreased appetite—Vincristine—muscle cancer	0.00228	0.00421	CcSEcCtD
Pentoxifylline—Convulsion—Etoposide—muscle cancer	0.00225	0.00416	CcSEcCtD
Pentoxifylline—Hypertension—Etoposide—muscle cancer	0.00224	0.00415	CcSEcCtD
Pentoxifylline—Constipation—Vincristine—muscle cancer	0.00224	0.00414	CcSEcCtD
Pentoxifylline—Chest pain—Etoposide—muscle cancer	0.00221	0.00409	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.0022	0.00406	CcSEcCtD
Pentoxifylline—Discomfort—Etoposide—muscle cancer	0.00219	0.00404	CcSEcCtD
Pentoxifylline—Hypersensitivity—Dactinomycin—muscle cancer	0.00216	0.00399	CcSEcCtD
Pentoxifylline—Abdominal discomfort—Methotrexate—muscle cancer	0.00214	0.00396	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Vincristine—muscle cancer	0.00214	0.00396	CcSEcCtD
Pentoxifylline—Confusional state—Etoposide—muscle cancer	0.00214	0.00395	CcSEcCtD
Pentoxifylline—Pancytopenia—Methotrexate—muscle cancer	0.00212	0.00392	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Etoposide—muscle cancer	0.00212	0.00392	CcSEcCtD
Pentoxifylline—Infection—Etoposide—muscle cancer	0.00211	0.00389	CcSEcCtD
Pentoxifylline—Asthenia—Dactinomycin—muscle cancer	0.0021	0.00389	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Etoposide—muscle cancer	0.00208	0.00384	CcSEcCtD
Pentoxifylline—Tachycardia—Etoposide—muscle cancer	0.00207	0.00383	CcSEcCtD
Pentoxifylline—Body temperature increased—Vincristine—muscle cancer	0.00207	0.00383	CcSEcCtD
Pentoxifylline—Abdominal pain—Vincristine—muscle cancer	0.00207	0.00383	CcSEcCtD
Pentoxifylline—Skin disorder—Etoposide—muscle cancer	0.00206	0.00381	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Etoposide—muscle cancer	0.00205	0.00379	CcSEcCtD
Pentoxifylline—Anorexia—Etoposide—muscle cancer	0.00202	0.00374	CcSEcCtD
Pentoxifylline—Diarrhoea—Dactinomycin—muscle cancer	0.002	0.00371	CcSEcCtD
Pentoxifylline—Infestation NOS—Methotrexate—muscle cancer	0.00199	0.00368	CcSEcCtD
Pentoxifylline—Infestation—Methotrexate—muscle cancer	0.00199	0.00368	CcSEcCtD
Pentoxifylline—Drowsiness—Methotrexate—muscle cancer	0.00199	0.00368	CcSEcCtD
Pentoxifylline—Hypotension—Etoposide—muscle cancer	0.00198	0.00366	CcSEcCtD
Pentoxifylline—Abdominal distension—Doxorubicin—muscle cancer	0.00195	0.0036	CcSEcCtD
Pentoxifylline—Conjunctivitis—Methotrexate—muscle cancer	0.00194	0.00358	CcSEcCtD
Pentoxifylline—Hypersensitivity—Vincristine—muscle cancer	0.00193	0.00357	CcSEcCtD
Pentoxifylline—Sweating—Methotrexate—muscle cancer	0.00191	0.00353	CcSEcCtD
Pentoxifylline—Dyspnoea—Etoposide—muscle cancer	0.00189	0.00349	CcSEcCtD
Pentoxifylline—Somnolence—Etoposide—muscle cancer	0.00189	0.00348	CcSEcCtD
Pentoxifylline—Angina pectoris—Doxorubicin—muscle cancer	0.00188	0.00348	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Methotrexate—muscle cancer	0.00188	0.00348	CcSEcCtD
Pentoxifylline—Epistaxis—Methotrexate—muscle cancer	0.00188	0.00347	CcSEcCtD
Pentoxifylline—Asthenia—Vincristine—muscle cancer	0.00188	0.00347	CcSEcCtD
Pentoxifylline—Vomiting—Dactinomycin—muscle cancer	0.00186	0.00344	CcSEcCtD
Pentoxifylline—Rash—Dactinomycin—muscle cancer	0.00185	0.00341	CcSEcCtD
Pentoxifylline—Decreased appetite—Etoposide—muscle cancer	0.00184	0.00341	CcSEcCtD
Pentoxifylline—Pancytopenia—Doxorubicin—muscle cancer	0.00184	0.0034	CcSEcCtD
Pentoxifylline—Constipation—Etoposide—muscle cancer	0.00181	0.00335	CcSEcCtD
Pentoxifylline—Haemoglobin—Methotrexate—muscle cancer	0.0018	0.00332	CcSEcCtD
Pentoxifylline—Diarrhoea—Vincristine—muscle cancer	0.00179	0.00331	CcSEcCtD
Pentoxifylline—Haemorrhage—Methotrexate—muscle cancer	0.00179	0.0033	CcSEcCtD
Pentoxifylline—Hepatitis—Methotrexate—muscle cancer	0.00179	0.0033	CcSEcCtD
Pentoxifylline—Feeling abnormal—Etoposide—muscle cancer	0.00175	0.00323	CcSEcCtD
Pentoxifylline—Nausea—Dactinomycin—muscle cancer	0.00174	0.00322	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Etoposide—muscle cancer	0.00173	0.00321	CcSEcCtD
Pentoxifylline—Dizziness—Vincristine—muscle cancer	0.00173	0.0032	CcSEcCtD
Pentoxifylline—Infestation NOS—Doxorubicin—muscle cancer	0.00172	0.00319	CcSEcCtD
Pentoxifylline—Infestation—Doxorubicin—muscle cancer	0.00172	0.00319	CcSEcCtD
Pentoxifylline—Drowsiness—Doxorubicin—muscle cancer	0.00172	0.00319	CcSEcCtD
Pentoxifylline—Urticaria—Etoposide—muscle cancer	0.00168	0.00311	CcSEcCtD
Pentoxifylline—Jaundice—Doxorubicin—muscle cancer	0.00168	0.00311	CcSEcCtD
Pentoxifylline—Body temperature increased—Etoposide—muscle cancer	0.00168	0.0031	CcSEcCtD
Pentoxifylline—Abdominal pain—Etoposide—muscle cancer	0.00168	0.0031	CcSEcCtD
Pentoxifylline—Conjunctivitis—Doxorubicin—muscle cancer	0.00168	0.0031	CcSEcCtD
Pentoxifylline—Vomiting—Vincristine—muscle cancer	0.00166	0.00308	CcSEcCtD
Pentoxifylline—Sweating—Doxorubicin—muscle cancer	0.00165	0.00306	CcSEcCtD
Pentoxifylline—Rash—Vincristine—muscle cancer	0.00165	0.00305	CcSEcCtD
Pentoxifylline—Dermatitis—Vincristine—muscle cancer	0.00165	0.00305	CcSEcCtD
Pentoxifylline—Headache—Vincristine—muscle cancer	0.00164	0.00303	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00163	0.00301	CcSEcCtD
Pentoxifylline—Epistaxis—Doxorubicin—muscle cancer	0.00163	0.00301	CcSEcCtD
Pentoxifylline—Immune system disorder—Methotrexate—muscle cancer	0.00161	0.00299	CcSEcCtD
Pentoxifylline—Hypersensitivity—Etoposide—muscle cancer	0.00156	0.00289	CcSEcCtD
Pentoxifylline—Erythema—Methotrexate—muscle cancer	0.00156	0.00288	CcSEcCtD
Pentoxifylline—Haemoglobin—Doxorubicin—muscle cancer	0.00156	0.00288	CcSEcCtD
Pentoxifylline—Nausea—Vincristine—muscle cancer	0.00155	0.00287	CcSEcCtD
Pentoxifylline—Haemorrhage—Doxorubicin—muscle cancer	0.00155	0.00286	CcSEcCtD
Pentoxifylline—Hepatitis—Doxorubicin—muscle cancer	0.00155	0.00286	CcSEcCtD
Pentoxifylline—Dysgeusia—Methotrexate—muscle cancer	0.00152	0.00282	CcSEcCtD
Pentoxifylline—Asthenia—Etoposide—muscle cancer	0.00152	0.00281	CcSEcCtD
Pentoxifylline—Back pain—Methotrexate—muscle cancer	0.00151	0.00278	CcSEcCtD
Pentoxifylline—Pruritus—Etoposide—muscle cancer	0.0015	0.00277	CcSEcCtD
Pentoxifylline—Vision blurred—Methotrexate—muscle cancer	0.00147	0.00271	CcSEcCtD
Pentoxifylline—Diarrhoea—Etoposide—muscle cancer	0.00145	0.00268	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Methotrexate—muscle cancer	0.00144	0.00267	CcSEcCtD
Pentoxifylline—Anaemia—Methotrexate—muscle cancer	0.00144	0.00266	CcSEcCtD
Pentoxifylline—Flushing—Doxorubicin—muscle cancer	0.00144	0.00266	CcSEcCtD
Pentoxifylline—Malaise—Methotrexate—muscle cancer	0.0014	0.00259	CcSEcCtD
Pentoxifylline—Dizziness—Etoposide—muscle cancer	0.0014	0.00259	CcSEcCtD
Pentoxifylline—Immune system disorder—Doxorubicin—muscle cancer	0.0014	0.00258	CcSEcCtD
Pentoxifylline—Leukopenia—Methotrexate—muscle cancer	0.00139	0.00258	CcSEcCtD
Pentoxifylline—Arrhythmia—Doxorubicin—muscle cancer	0.00138	0.00256	CcSEcCtD
Pentoxifylline—Convulsion—Methotrexate—muscle cancer	0.00135	0.00249	CcSEcCtD
Pentoxifylline—Vomiting—Etoposide—muscle cancer	0.00135	0.00249	CcSEcCtD
Pentoxifylline—Erythema—Doxorubicin—muscle cancer	0.00135	0.00249	CcSEcCtD
Pentoxifylline—Rash—Etoposide—muscle cancer	0.00134	0.00247	CcSEcCtD
Pentoxifylline—Dermatitis—Etoposide—muscle cancer	0.00134	0.00247	CcSEcCtD
Pentoxifylline—Headache—Etoposide—muscle cancer	0.00133	0.00246	CcSEcCtD
Pentoxifylline—Flatulence—Doxorubicin—muscle cancer	0.00133	0.00245	CcSEcCtD
Pentoxifylline—Chest pain—Methotrexate—muscle cancer	0.00133	0.00245	CcSEcCtD
Pentoxifylline—Myalgia—Methotrexate—muscle cancer	0.00133	0.00245	CcSEcCtD
Pentoxifylline—Tension—Doxorubicin—muscle cancer	0.00132	0.00244	CcSEcCtD
Pentoxifylline—Dysgeusia—Doxorubicin—muscle cancer	0.00132	0.00244	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00132	0.00243	CcSEcCtD
Pentoxifylline—Discomfort—Methotrexate—muscle cancer	0.00131	0.00242	CcSEcCtD
Pentoxifylline—Nervousness—Doxorubicin—muscle cancer	0.00131	0.00242	CcSEcCtD
Pentoxifylline—Back pain—Doxorubicin—muscle cancer	0.0013	0.00241	CcSEcCtD
Pentoxifylline—Muscle spasms—Doxorubicin—muscle cancer	0.0013	0.0024	CcSEcCtD
Pentoxifylline—Confusional state—Methotrexate—muscle cancer	0.00128	0.00237	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Methotrexate—muscle cancer	0.00127	0.00235	CcSEcCtD
Pentoxifylline—Vision blurred—Doxorubicin—muscle cancer	0.00127	0.00235	CcSEcCtD
Pentoxifylline—Infection—Methotrexate—muscle cancer	0.00126	0.00233	CcSEcCtD
Pentoxifylline—Nausea—Etoposide—muscle cancer	0.00126	0.00233	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Doxorubicin—muscle cancer	0.00125	0.00231	CcSEcCtD
Pentoxifylline—Anaemia—Doxorubicin—muscle cancer	0.00125	0.0023	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Methotrexate—muscle cancer	0.00124	0.0023	CcSEcCtD
Pentoxifylline—Agitation—Doxorubicin—muscle cancer	0.00124	0.00229	CcSEcCtD
Pentoxifylline—Skin disorder—Methotrexate—muscle cancer	0.00123	0.00228	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Methotrexate—muscle cancer	0.00123	0.00227	CcSEcCtD
Pentoxifylline—Malaise—Doxorubicin—muscle cancer	0.00122	0.00225	CcSEcCtD
Pentoxifylline—Anorexia—Methotrexate—muscle cancer	0.00121	0.00224	CcSEcCtD
Pentoxifylline—Leukopenia—Doxorubicin—muscle cancer	0.00121	0.00223	CcSEcCtD
Pentoxifylline—Palpitations—Doxorubicin—muscle cancer	0.00119	0.0022	CcSEcCtD
Pentoxifylline—Hypotension—Methotrexate—muscle cancer	0.00119	0.00219	CcSEcCtD
Pentoxifylline—Convulsion—Doxorubicin—muscle cancer	0.00117	0.00216	CcSEcCtD
Pentoxifylline—Hypertension—Doxorubicin—muscle cancer	0.00116	0.00215	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00116	0.00214	CcSEcCtD
Pentoxifylline—Insomnia—Methotrexate—muscle cancer	0.00115	0.00212	CcSEcCtD
Pentoxifylline—Myalgia—Doxorubicin—muscle cancer	0.00115	0.00212	CcSEcCtD
Pentoxifylline—Chest pain—Doxorubicin—muscle cancer	0.00115	0.00212	CcSEcCtD
Pentoxifylline—Anxiety—Doxorubicin—muscle cancer	0.00114	0.00211	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00114	0.00211	CcSEcCtD
Pentoxifylline—Discomfort—Doxorubicin—muscle cancer	0.00113	0.0021	CcSEcCtD
Pentoxifylline—Dyspnoea—Methotrexate—muscle cancer	0.00113	0.00209	CcSEcCtD
Pentoxifylline—Somnolence—Methotrexate—muscle cancer	0.00113	0.00209	CcSEcCtD
Pentoxifylline—Dry mouth—Doxorubicin—muscle cancer	0.00112	0.00207	CcSEcCtD
Pentoxifylline—Dyspepsia—Methotrexate—muscle cancer	0.00112	0.00207	CcSEcCtD
Pentoxifylline—Confusional state—Doxorubicin—muscle cancer	0.00111	0.00205	CcSEcCtD
Pentoxifylline—Decreased appetite—Methotrexate—muscle cancer	0.0011	0.00204	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Doxorubicin—muscle cancer	0.0011	0.00203	CcSEcCtD
Pentoxifylline—Oedema—Doxorubicin—muscle cancer	0.0011	0.00203	CcSEcCtD
Pentoxifylline—Infection—Doxorubicin—muscle cancer	0.00109	0.00202	CcSEcCtD
Pentoxifylline—Shock—Doxorubicin—muscle cancer	0.00108	0.002	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Doxorubicin—muscle cancer	0.00108	0.00199	CcSEcCtD
Pentoxifylline—Tachycardia—Doxorubicin—muscle cancer	0.00107	0.00198	CcSEcCtD
Pentoxifylline—Skin disorder—Doxorubicin—muscle cancer	0.00107	0.00197	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Doxorubicin—muscle cancer	0.00106	0.00197	CcSEcCtD
Pentoxifylline—Anorexia—Doxorubicin—muscle cancer	0.00105	0.00194	CcSEcCtD
Pentoxifylline—Feeling abnormal—Methotrexate—muscle cancer	0.00105	0.00193	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Methotrexate—muscle cancer	0.00104	0.00192	CcSEcCtD
Pentoxifylline—Hypotension—Doxorubicin—muscle cancer	0.00103	0.0019	CcSEcCtD
Pentoxifylline—Urticaria—Methotrexate—muscle cancer	0.00101	0.00187	CcSEcCtD
Pentoxifylline—Abdominal pain—Methotrexate—muscle cancer	0.001	0.00186	CcSEcCtD
Pentoxifylline—Body temperature increased—Methotrexate—muscle cancer	0.001	0.00186	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.001	0.00185	CcSEcCtD
Pentoxifylline—Insomnia—Doxorubicin—muscle cancer	0.000995	0.00184	CcSEcCtD
Pentoxifylline—Dyspnoea—Doxorubicin—muscle cancer	0.000981	0.00181	CcSEcCtD
Pentoxifylline—Somnolence—Doxorubicin—muscle cancer	0.000978	0.00181	CcSEcCtD
Pentoxifylline—Dyspepsia—Doxorubicin—muscle cancer	0.000968	0.00179	CcSEcCtD
Pentoxifylline—Decreased appetite—Doxorubicin—muscle cancer	0.000956	0.00177	CcSEcCtD
Pentoxifylline—Constipation—Doxorubicin—muscle cancer	0.000941	0.00174	CcSEcCtD
Pentoxifylline—Hypersensitivity—Methotrexate—muscle cancer	0.000936	0.00173	CcSEcCtD
Pentoxifylline—Asthenia—Methotrexate—muscle cancer	0.000911	0.00168	CcSEcCtD
Pentoxifylline—Feeling abnormal—Doxorubicin—muscle cancer	0.000906	0.00168	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000899	0.00166	CcSEcCtD
Pentoxifylline—Pruritus—Methotrexate—muscle cancer	0.000899	0.00166	CcSEcCtD
Pentoxifylline—Urticaria—Doxorubicin—muscle cancer	0.000874	0.00162	CcSEcCtD
Pentoxifylline—Abdominal pain—Doxorubicin—muscle cancer	0.000869	0.00161	CcSEcCtD
Pentoxifylline—Body temperature increased—Doxorubicin—muscle cancer	0.000869	0.00161	CcSEcCtD
Pentoxifylline—Diarrhoea—Methotrexate—muscle cancer	0.000869	0.00161	CcSEcCtD
Pentoxifylline—Dizziness—Methotrexate—muscle cancer	0.00084	0.00155	CcSEcCtD
Pentoxifylline—Hypersensitivity—Doxorubicin—muscle cancer	0.00081	0.0015	CcSEcCtD
Pentoxifylline—Vomiting—Methotrexate—muscle cancer	0.000808	0.00149	CcSEcCtD
Pentoxifylline—Rash—Methotrexate—muscle cancer	0.000801	0.00148	CcSEcCtD
Pentoxifylline—Dermatitis—Methotrexate—muscle cancer	0.0008	0.00148	CcSEcCtD
Pentoxifylline—Headache—Methotrexate—muscle cancer	0.000796	0.00147	CcSEcCtD
Pentoxifylline—Asthenia—Doxorubicin—muscle cancer	0.000789	0.00146	CcSEcCtD
Pentoxifylline—Pruritus—Doxorubicin—muscle cancer	0.000778	0.00144	CcSEcCtD
Pentoxifylline—Nausea—Methotrexate—muscle cancer	0.000754	0.00139	CcSEcCtD
Pentoxifylline—Diarrhoea—Doxorubicin—muscle cancer	0.000753	0.00139	CcSEcCtD
Pentoxifylline—Dizziness—Doxorubicin—muscle cancer	0.000727	0.00134	CcSEcCtD
Pentoxifylline—Vomiting—Doxorubicin—muscle cancer	0.000699	0.00129	CcSEcCtD
Pentoxifylline—Rash—Doxorubicin—muscle cancer	0.000693	0.00128	CcSEcCtD
Pentoxifylline—Dermatitis—Doxorubicin—muscle cancer	0.000693	0.00128	CcSEcCtD
Pentoxifylline—Headache—Doxorubicin—muscle cancer	0.000689	0.00127	CcSEcCtD
Pentoxifylline—Nausea—Doxorubicin—muscle cancer	0.000653	0.00121	CcSEcCtD
